{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:49:15Z","timestamp":1767134955780,"version":"build-2238731810"},"publisher-location":"Chichester, UK","reference-count":62,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd000239","type":"reference-entry","created":{"date-parts":[[2003,11,20]],"date-time":"2003-11-20T16:45:34Z","timestamp":1069346734000},"source":"Crossref","is-referenced-by-count":20,"title":["Amphotericin B versus fluconazole for controlling fungal infections in neutropenic cancer patients"],"prefix":"10.1002","author":[{"given":"Helle Krogh","family":"Johansen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter C","family":"G\u00f8tzsche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,4,22]]},"reference":[{"key":"10.1002\/14651858.CD000239-BIB1|cit1","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1439-0507.1993.tb00725.x","article-title":"Fluconazole versus oral amphotericin B in preventing fungal infection in chemotherapy-induced neutropenic patients with haematological malignancies","volume":"36","author":"Akiyama","year":"1993","journal-title":"Mycoses"},{"key":"10.1002\/14651858.CD000239-BIB2|cit2","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1093\/clinids\/23.5.964","article-title":"Management of invasive candidal infections: results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature","volume":"23","author":"Anaissie","year":"1996","journal-title":"Clinical Infectious Diseases"},{"key":"10.1002\/14651858.CD000239-BIB3|cit3","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/1097-0142(19940415)73:8<2099::AID-CNCR2820730814>3.0.CO;2-N","article-title":"Antifungal prophylaxis during remission induction therapy for acute leukemia fluconazole versus intravenous amphotericin B","volume":"73","author":"Bodey","year":"1994","journal-title":"Cancer"},{"issue":"4","key":"10.1002\/14651858.CD000239-BIB4|cit4","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/ajh.10234","article-title":"Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantation","volume":"71","author":"Koh","year":"2002","journal-title":"American Journal of Hematology"},{"key":"10.1002\/14651858.CD000239-BIB5|cit5","series-title":"Proceedings of the Annual Meeting of American Society for Clinical Oncology","first-page":"344 (abstract 1","article-title":"A randomized trial of Fluconazole vs. Amphotericin B for the treatment of Esophageal candidiasis in the adult cancer patient","author":"Lake","year":"1991"},{"key":"10.1002\/14651858.CD000239-BIB6|cit6","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1159\/000239459","article-title":"Fluconazole versus amphotericin B in the treatment of esophageal candidiasis in cancer patients","volume":"42","author":"Lake","year":"1996","journal-title":"Chemotherapy"},{"issue":"6","key":"10.1002\/14651858.CD000239-BIB7|cit7","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0002-9343(98)00326-X","article-title":"A randomized comparison of fluconazole with amphotericin B as empiric anti-fungal agents in cancer patients with prolonged fever and neutropenia","volume":"105","author":"Malik","year":"1998","journal-title":"American Journal of Medicine"},{"key":"10.1002\/14651858.CD000239-BIB8|cit8","series-title":"32nd Interscience Conference on Antimicrobial Agents and Chemotherapy, October 1992, Anaheim, California","first-page":"abstract no 624","article-title":"Intravenous fluconazole (Flu) versus intravenous Amphotericin B (AmB) in the management of febrile neutropenic patients: a multicentric randomized study","author":"Lapierre","year":"1992"},{"key":"10.1002\/14651858.CD000239-BIB9|cit9","first-page":"171","article-title":"Etude multicentrique randomis\u00e9e fluconazole iv versus amphot\u00e9ricine B iv chez le patient neutrop\u00e9nique et f\u00e9brile","volume":"2","author":"Marie","year":"1993","journal-title":"Cahiers d'Oncologie"},{"key":"10.1002\/14651858.CD000239-BIB10|cit10","series-title":"7th European Congress of Clinical Microbiology and Infectious Diseases, March 26 to March 30, 1995, Vienna, Austria","first-page":"abstract no 70,","article-title":"European studies of fluconazole (F) vs amphotericin B (AmB) in febrile neutropenic cancer patients","author":"Viscoli","year":"1995"},{"key":"10.1002\/14651858.CD000239-BIB11|cit11","doi-asserted-by":"crossref","first-page":"913","DOI":"10.7326\/0003-4819-120-11-199406010-00003","article-title":"Preventing fungal infection in neutropenic patients with acute leukemia: fluconazole compared with oral amphotericin B. The GIMEMA Infection Program","volume":"120","author":"Menichetti","year":"1994","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD000239-BIB12|cit12","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/BF03259575","article-title":"Chemoprophylaxis of fungal infections in granulocytopenic patients using fluconazole vs oral amphotericin B","volume":"3","author":"Meunier","year":"1991","journal-title":"Drug Investigation"},{"key":"10.1002\/14651858.CD000239-BIB13|cit13","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1093\/jac\/40.6.855","article-title":"Fluconazole versus nystatin in the prevention of candida infections in children and adolescents undergoing remission induction or consolidation chemotherapy for cancer","volume":"40","author":"Groll","year":"1997","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1002\/14651858.CD000239-BIB14|cit14","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/BF01974614","article-title":"A multicentre study of fluconazole versus oral polyenes in the prevention of fungal infection in children with hematological or oncological malignancies. Multicentre Study Group","volume":"13","author":"Ninane","year":"1994","journal-title":"European Journal of Clinical Microbiology and Infectious Diseases"},{"key":"10.1002\/14651858.CD000239-BIB15|cit15","first-page":"546","article-title":"Management of fungal infection in neutropenic patients with fluconazole","volume":"33","author":"Brammer","year":"1990","journal-title":"Hamatology and Blood Transfusion"},{"key":"10.1002\/14651858.CD000239-BIB16|cit16","first-page":"42","article-title":"[Comparison of oral fluconazole and amphotericin B prophylaxis against fungal infections in the neutropenic phase of patients treated with antileukemic agents]","volume":"33 Suppl 1","author":"Finke","journal-title":"Mycoses"},{"issue":"6","key":"10.1002\/14651858.CD000239-BIB17|cit17","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/jac\/31.6.973","article-title":"Randomized comparison of oral fluconazole versus oral polyenes for the prevention of fungal infection in patients at risk of neutropenia. Multicentre Study Group","volume":"31","author":"Philpott Howard","year":"1993","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"3","key":"10.1002\/14651858.CD000239-BIB18|cit18","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/jac\/27.3.369","article-title":"A randomized study to compare oral fluconazole to amphotericin B in the prevention of fungal infections in patients with acute leukaemia","volume":"27","author":"Rozenberg Arska","year":"1991","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1002\/14651858.CD000239-BIB19|cit19","first-page":"A120, abstract","article-title":"Oral fluconazole (F) vs oral polyenes (P) as antimycotic prophylaxis in neutropenia: an European multicenter study","volume":"65","author":"Schuler","year":"1992","journal-title":"Annals of Hematology"},{"key":"10.1002\/14651858.CD000239-BIB20|cit20","first-page":"27 (abstract)","article-title":"Fluconazole versus polyenes as oral anti-fungal prophylaxis in autologous and allogeneic bone marrow recipients","volume":"4 suppl 2","author":"Milliken","year":"1989","journal-title":"Bone Marrow Transplantation"},{"key":"10.1002\/14651858.CD000239-BIB21|cit21","first-page":"135, abstract 2","article-title":"Antifungal prophylaxis with fluconazole in bone marrow transplants","volume":"5 suppl 2","author":"Powles","year":"1990","journal-title":"Bone Marrow Transplantation"},{"key":"10.1002\/14651858.CD000239-BIB22|cit22","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1439-0507.1999.tb00023.x","article-title":"Early empiric antifungal therapy of infections in neutropenic patients comparing fluconazole with amphotericin B\/flucytosine","volume":"42(suppl 2)","author":"Silling","year":"1999","journal-title":"Mycoses"},{"key":"10.1002\/14651858.CD000239-BIB23|cit23","first-page":"159","article-title":"Early empiric antifungal therapy of infections in neutropenic patients comparing fluconazole with amphotericin B\/5-fluorocytosine","volume":"42(3)","author":"Silling","year":"1999","journal-title":"Mycoses"},{"key":"10.1002\/14651858.CD000239-BIB24|cit24","first-page":"S2, abstract 8","article-title":"Early empiric antifungal therapy of infections in neutropenic patients with hematologic malignancies: fluconazole vs ampho B\/5-FC","volume":"78(suppl 1)","author":"Silling","year":"1999","journal-title":"Annals of Hematology"},{"key":"10.1002\/14651858.CD000239-BIB25|cit25","first-page":"A101, abstract","article-title":"Fluconazole (FCA) versus amphotericin B\/5-flucytosine (ABF) for the treatment of febrile neutropenia","volume":"70(suppl 1)","author":"Silling","year":"1995","journal-title":"Annals of Hematology"},{"issue":"suppl 1","key":"10.1002\/14651858.CD000239-BIB26|cit26","first-page":"306a","article-title":"Early empiric antifungal treatment of infections in neutropenic patients comparing fluconazole with amphotericin B\/5-flucytosine","volume":"10","author":"Silling-Engelhardt","year":"1994","journal-title":"Blood"},{"key":"10.1002\/14651858.CD000239-BIB27|cit27","first-page":"A110, abstract","article-title":"Interventional treatment of unexplained fever (FUO) and documented infections in neutropenic patients with hematologic malignancies: fluconazole versus ampho B\/5-FC","volume":"64","author":"Silling-Engelhardt","year":"1992","journal-title":"Annals of Hematology"},{"key":"10.1002\/14651858.CD000239-BIB28|cit28","first-page":"535","article-title":"A randomised study to compare oral fluconazole with oral amphotericin B for suppression of fungal flora and prevention of fungal infection in bone marrow transplantation recipients","volume":"7","author":"Teshima","year":"1994","journal-title":"Drug Evaluation (Konnichi No Ishoku)"},{"issue":"5","key":"10.1002\/14651858.CD000239-BIB29|cit29","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/0959-8049(95)00619-2","article-title":"Fluconazole versus amphotericin B as empirical antifungal therapy of unexplained fever in granulocytopenic cancer patients: a pragmatic, multicentre, prospective and randomised clinical trial","volume":"32A","author":"Viscoli","year":"1996","journal-title":"European Journal of Cancer"},{"key":"10.1002\/14651858.CD000239-BIB30|cit30","series-title":"20th International Congress of Chemotherapy, June 29 to July 3, 1997, Sydney, Australia","first-page":"abstract no 324","article-title":"Fluconazole versus amphotericin B for empiric antifungal therapy of febrile neutropenic patients: results of a randomised multicenter trial","author":"Winston","year":"1997"},{"key":"10.1002\/14651858.CD000239-BIB31|cit31","series-title":"10th International Symposium on Infections in the Immunocomprised Host, June 21-24, 1998, Davos, Switzerland","first-page":"abstract no 112","article-title":"Fluconazole versus amphotericin B for empiric antifungal therapy of febrile neutropenic patients: results of a randomized multi-center trial","author":"Winston","year":"1998"},{"key":"10.1002\/14651858.CD000239-BIB32|cit32","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0002-9343(99)00457-X","article-title":"A multicenter, randomized trial of fluconazole versus amphotericin B for empiric antifungal therapy of febrile neutropenic patients with cancer","volume":"108","author":"Winston","year":"2000","journal-title":"American Journal of Medicine"},{"issue":"8","key":"10.1002\/14651858.CD000239-BIB33|cit33","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/sj.bmt.1702233","article-title":"Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group","volume":"25","author":"Wolff","year":"2000","journal-title":"Bone Marrow Transplantation"},{"key":"10.1002\/14651858.CD000239-BIB34|cit34","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0163-4453(95)80009-3","article-title":"Systemic amphotericin B versus fluconazole in the management of antibiotic resistant neutropenic fever - preliminary observations from a pilot, exploratory study","volume":"30","author":"Ellis","year":"1995","journal-title":"Journal of Infection"},{"key":"10.1002\/14651858.CD000239-BIB35|cit35","series-title":"Proceedings of the Annual Meeting of American Society for Clinical Oncology","first-page":"465 (abstract A","article-title":"Interim analysis of fluconazole (flu), intermittent amphotericin (ampho) and no treatment (ntx) for prophylaxis of fungal disease in bone marrow transplant (BMT) and acute leukemia (AL) patients (pts)","author":"Reed","year":"1993"},{"issue":"8","key":"10.1002\/14651858.CD000239-BIB36|cit36","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/sj.bmt.1702243","article-title":"Amphotericin B colloidal dispersion (Amphocil) vs fluconazole for the prevention of fungal infections in neutropenic patients: data of a prematurely stopped clinical trial","volume":"25","author":"Timmers","year":"2000","journal-title":"Bone Marrow Transplantation"},{"key":"10.1002\/14651858.CD000239-BIB37|cit37","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00005792-197405000-00004","article-title":"Effect of prophylactic measures on the microbial flora of patients in protected environment units","volume":"53","author":"Bodey","year":"1974","journal-title":"Medicine"},{"key":"10.1002\/14651858.CD000239-BIB38|cit38","series-title":"37th Interscience Conference on Antimicrobial Agents and Chemotherapy, September 28 to October 1, 1997, Toronto, Ontario, Canada","first-page":"abstract no LM-","article-title":"Antifungal prophylaxis in neutropenic cancer patients - a meta-analysis","author":"Bow","year":"1997"},{"key":"10.1002\/14651858.CD000239-BIB39|cit39","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1002\/cncr.10610","article-title":"Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta analysis of randomized-controlled clinical trials","volume":"94","author":"Bow","year":"2002","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD000239-BIB40|cit40","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-2288-6-40","article-title":"Fungal infection-related mortality versus total mortality as an outcome in trials of antifungal agents","volume":"6","author":"Due","year":"2006","journal-title":"BioMed Central Medical Research Methodology"},{"key":"10.1002\/14651858.CD000239-BIB41|cit41","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1128\/AAC.36.1.172","article-title":"Double-blind randomized study of the effect of infusion rates on toxicity of amphotericin B","volume":"36","author":"Ellis","year":"1992","journal-title":"Antimicrobial Agents & Chemotherapy"},{"issue":"7286","key":"10.1002\/14651858.CD000239-BIB42|cit42","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1136\/bmj.322.7286.579","article-title":"Comparison of effects of amphotericin B deoxycholate infused over 4 or 24 hours: randomised controlled trial","volume":"322","author":"Eriksson","year":"2001","journal-title":"BMJ"},{"issue":"13","key":"10.1002\/14651858.CD000239-BIB43|cit43","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1056\/NEJM199203263261301","article-title":"A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation","volume":"326","author":"Goodman","year":"1992","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD000239-BIB44|cit44","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1093\/jac\/40.6.855","article-title":"Fluconazole versus nystatin in the prevention of candida infections in children and adolescents undergoing remission induction or consolidation chemotherapy for cancer","volume":"40","author":"Groll","year":"1997","journal-title":"The Journal of Antimicrobial Chemotherapy"},{"key":"10.1002\/14651858.CD000239-BIB45|cit45","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1136\/bmj.314.7089.1238","article-title":"Meta-analysis of prophylactic or empirical antifungal treatment versus placebo or no treatment in patients with cancer complicated by neutropenia","volume":"314","author":"G\u00f8tzsche","year":"1997","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD000239-BIB46|cit46","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000026","article-title":"Routine versus selective antifungal administration for control of fungal infections in patients with cancer","author":"G\u00f8tzsche","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD000239-BIB47|cit47","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002033","article-title":"Nystatin prophylaxis and treatment in severely immunodepressed patients","author":"G\u00f8tzsche","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD000239-BIB48|cit48","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1136\/bmj.280.6217.833","article-title":"Study of information submitted by drug companies to licensing authorities","volume":"March 22","author":"Hemminki","year":"1980","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000239-BIB49|cit49","series-title":"37th Interscience Conference on Antimicrobial Agents and Chemotherapy, September 28 to October 1, 1997, Toronto, Ontario, Canada","first-page":"abstract no LM-","article-title":"Systematic reviews of prophylactic or empirical antifungal therapy in cancer patients with neutropenia","author":"Johansen","year":"1997"},{"issue":"1","key":"10.1002\/14651858.CD000239-BIB50|cit50","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s005200050224","article-title":"Must we really fear toxicity of conventional amphotericin B in oncological patients?","volume":"7","author":"Mayer","year":"1999","journal-title":"Support Care Cancer"},{"key":"10.1002\/14651858.CD000239-BIB51|cit51","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1136\/bmj.306.6885.1125-b","article-title":"Effective and acceptable treatment for depression (letter)","volume":"306","author":"Nakielny","year":"1993","journal-title":"BMJ"},{"issue":"6","key":"10.1002\/14651858.CD000239-BIB52|cit52","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1128\/AAC.43.6.1417","article-title":"Amphotericin B in children with malignant disease: a comparison of the toxicities and pharmacokinetics of amphotericin B administered in dextrose versus lipid emulsion","volume":"43","author":"Nath","year":"1999","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"6","key":"10.1002\/14651858.CD000239-BIB53|cit53","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/infdis\/171.6.1545","article-title":"Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation - a prospective, randomized, double-blind study","volume":"171","author":"Slavin","year":"1995","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD000239-BIB54|cit54","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1136\/bmj.316.7126.221","article-title":"Unresolved issues and future developments","volume":"316","author":"Smith","year":"1998","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000239-BIB55|cit55","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1136\/bmj.306.6879.683","article-title":"Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability","volume":"306","author":"Song","year":"1993","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000239-BIB56|cit56","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1136\/bmj.315.7109.640","article-title":"Publication bias: evidence of delayed publication in a cohort study of clinical research projects","volume":"315","author":"Stern","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000239-BIB57|cit57","first-page":"177","article-title":"Candida infections in bone marrow transplant recipients","volume":"8","author":"Verfaillie","year":"1991","journal-title":"Bone Marrow Transplant"},{"key":"10.1002\/14651858.CD000239-BIB58|cit58","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/0959-8049(94)90412-X","article-title":"Factors associated with bacteraemia in febrile, granulocytopenic cancer patients","volume":"30A","author":"Viscoli","year":"1994","journal-title":"European Journal of Cancer"},{"key":"10.1002\/14651858.CD000239-BIB59|cit59","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/jac\/36.6.899","article-title":"Antifungal drug chemotherapy . Antifungal drug susceptibility testing","volume":"36","year":"1995","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1002\/14651858.CD000239-BIB60|cit60","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1001\/jama.282.18.1752","article-title":"Problems in the design and reporting of trials of antifungal agents encountered during meta-analysis","volume":"282","author":"Johansen","year":"1999","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD000239-BIB61|cit61","article-title":"Amphotericin B versus fluconazole for controlling fungal infections in neutropenic cancer patients","author":"Johansen","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD000239-BIB62|cit62","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000239","article-title":"Amphotericin B versus fluconazole for controlling fungal infections in neutropenic cancer patients","author":"Johansen","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd000239.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,9,4]],"date-time":"2014-09-04T00:00:00Z","timestamp":1409788800000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD000239\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T16:55:45Z","timestamp":1628528145000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD000239"}},"subtitle":[],"editor":[{"given":"Helle Krogh","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2002,4,22]]},"references-count":62,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd000239","relation":{},"subject":[],"published":{"date-parts":[[2002,4,22]]}}}